Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report.

Recovery from COVID-19 is associated with production of anti-SARS-CoV-2 antibodies, but it is uncertain whether these confer immunity. We describe viral RNA shedding duration in hospitalized patients and identify patients with recurrent shedding. We sequenced viruses from two distinct episodes of symptomatic COVID-19 separated by 144 days in a single patient, to conclusively describe reinfection with a new strain harboring the spike variant D614G. With antibody and B cell analytics, we show correlates of adaptive immunity, including a differential response to D614G. Finally, we discuss implications for vaccine programs and begin to define benchmarks for protection against reinfection from SARS-CoV-2.

[1]  B. Zikmund‐Fisher,et al.  Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States , 2021, Frontiers in Immunology.

[2]  Trevor Bedford,et al.  Cryptic transmission of SARS-CoV-2 in Washington state , 2020, Science.

[3]  Howard Y. Chang,et al.  Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[4]  K. To,et al.  COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Bloom,et al.  Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate , 2020, Journal of Clinical Microbiology.

[6]  J. Sevinsky,et al.  Genomic Evidence for a Case of Reinfection with SARS-CoV-2 , 2020, SSRN Electronic Journal.

[7]  R. Tibshirani,et al.  SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness , 2020, medRxiv.

[8]  J. Bloom,et al.  Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate , 2020, medRxiv.

[9]  A. Casadevall,et al.  Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience , 2020, medRxiv.

[10]  Pei Wang.  Recurrent presence of SARS‐CoV‐2 RNA in a 33‐year‐old man , 2020, Journal of medical virology.

[11]  Nguyen H. Tran,et al.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.

[12]  Susan R. Wilcox,et al.  A case report of possible novel coronavirus 2019 reinfection , 2020, The American Journal of Emergency Medicine.

[13]  S. Rowland-Jones,et al.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.

[14]  M. M. van der Eerden,et al.  Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants , 2020, medRxiv.

[15]  John R. Mascola,et al.  A strategic approach to COVID-19 vaccine R&D , 2020, Science.

[16]  Mark S. Anderson,et al.  Test performance evaluation of SARS-CoV-2 serological assays , 2020, medRxiv.

[17]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[18]  Zhengrong Yang,et al.  Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation , 2020, Scientific Reports.

[19]  Jun Liu,et al.  Factors associated with prolonged viral RNA shedding in patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[21]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[22]  J. Quick,et al.  nCoV-2019 sequencing protocol v1 , 2020 .

[23]  Trevor Bedford,et al.  Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.